These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 20075511)

  • 21. The relationship between serum levels of surfactant protein D in COPD exacerbation severity and mortality.
    Günaydın FE; Günlüoğlu G; Kalkan N; Aktepe EN; Demirkol B; Altın S
    Turk J Med Sci; 2019 Jun; 49(3):888-893. PubMed ID: 31083857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of Serum Vitamin D (25OHD) Level with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
    Islam S; Sarkar NK; Mujahid AA; Bennoor KS; Hossain SS; Attar MM; Jahan R; Hossain MA; Chowdhury HA; Ali L
    Mymensingh Med J; 2019 Apr; 28(2):441-448. PubMed ID: 31086164
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum CCL-18 level is a risk factor for COPD exacerbations requiring hospitalization.
    Dilektasli AG; Demirdogen Cetinoglu E; Uzaslan E; Budak F; Coskun F; Ursavas A; Ercan I; Ege E
    Int J Chron Obstruct Pulmon Dis; 2017; 12():199-208. PubMed ID: 28115842
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum Levels of Gamma-Glutamyltransferase During Stable and Acute Exacerbations of Chronic Obstructive Pulmonary Disease.
    Sun D; Liu H; Ouyang Y; Liu X; Xu Y
    Med Sci Monit; 2020 Oct; 26():e927771. PubMed ID: 33087693
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum Surfactant Protein D as a Biomarker for Measuring Lung Involvement in Obese Patients With Type 2 Diabetes.
    López-Cano C; Lecube A; García-Ramírez M; Muñoz X; Sánchez E; Seminario A; Hernández M; Ciudin A; Gutiérrez L; Hernández C; Simó R
    J Clin Endocrinol Metab; 2017 Nov; 102(11):4109-4116. PubMed ID: 28945872
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Club Cell-16 and RelB as Novel Determinants of Arterial Stiffness in Exacerbating COPD Patients.
    Labonté LE; Bourbeau J; Daskalopoulou SS; Zhang M; Coulombe P; Garland K; Baglole CJ
    PLoS One; 2016; 11(2):e0149974. PubMed ID: 26914709
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum Endostatin Is a Novel Marker for COPD Associated with Lower Lung Function, Exacerbation and Systemic Inflammation.
    Wu Y; Qin J; He J; Shen Y; Wang H; Li Y; Zeng Q; Dong J; An Y; Xiong S; Feng M; Wen F
    Int J Chron Obstruct Pulmon Dis; 2020; 15():397-407. PubMed ID: 32158205
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of single vs bilateral lung transplantation on plasma surfactant protein D levels in idiopathic pulmonary fibrosis.
    Sims MW; Beers MF; Ahya VN; Kawut SM; Sims KD; Lederer DJ; Palmer SM; Wille K; Lama VN; Shah PD; Orens JB; Bhorade S; Crespo M; Weinacker A; Demissie E; Bellamy S; Christie JD; Ware LB;
    Chest; 2011 Aug; 140(2):489-496. PubMed ID: 21349925
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Integrating lung and plasma expression of pneumo-proteins in developing biomarkers in COPD: a case study of surfactant protein D.
    Tkacova R; McWilliams A; Lam S; Sin DD
    Med Sci Monit; 2010 Nov; 16(11):CR540-4. PubMed ID: 20980958
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevated circulating PAI-1 levels are related to lung function decline, systemic inflammation, and small airway obstruction in chronic obstructive pulmonary disease.
    Wang H; Yang T; Li D; Wu Y; Zhang X; Pang C; Zhang J; Ying B; Wang T; Wen F
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2369-2376. PubMed ID: 27713627
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surfactant protein D multimerization and gene polymorphism in COPD and asthma.
    Fakih D; Akiki Z; Junker K; Medlej-Hashim M; Waked M; Salameh P; Holmskov U; Bouharoun-Tayoun H; Chamat S; Sorensen GL; Jounblat R
    Respirology; 2018 Mar; 23(3):298-305. PubMed ID: 28960651
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute Exacerbations and Lung Function Loss in Smokers with and without Chronic Obstructive Pulmonary Disease.
    Dransfield MT; Kunisaki KM; Strand MJ; Anzueto A; Bhatt SP; Bowler RP; Criner GJ; Curtis JL; Hanania NA; Nath H; Putcha N; Roark SE; Wan ES; Washko GR; Wells JM; Wendt CH; Make BJ;
    Am J Respir Crit Care Med; 2017 Feb; 195(3):324-330. PubMed ID: 27556408
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surfactant protein D, soluble intercellular adhesion molecule-1 and high-sensitivity C-reactive protein as biomarkers of chronic obstructive pulmonary disease.
    El-Deek SE; Makhlouf HA; Saleem TH; Mandour MA; Mohamed NA
    Med Princ Pract; 2013; 22(5):469-74. PubMed ID: 23860258
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Value of serum and induced sputum surfactant protein-D in chronic obstructive pulmonary disease.
    Ozyurek BA; Ulasli SS; Bozbas SS; Bayraktar N; Akcay S
    Multidiscip Respir Med; 2013 Jun; 8(1):36. PubMed ID: 23725346
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical significance of nuclear factor erythroid 2-related factor 2 in patients with chronic obstructive pulmonary disease.
    Ban WH; Kang HH; Kim IK; Ha JH; Joo H; Lee JM; Lim JU; Lee SH; Rhee CK
    Korean J Intern Med; 2018 Jul; 33(4):745-752. PubMed ID: 29529843
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surfactant protein A as a biomarker of outcomes of anti-fibrotic drug therapy in patients with idiopathic pulmonary fibrosis.
    Yoshikawa T; Otsuka M; Chiba H; Ikeda K; Mori Y; Umeda Y; Nishikiori H; Kuronuma K; Takahashi H
    BMC Pulm Med; 2020 Jan; 20(1):27. PubMed ID: 32005219
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical features of Japanese patients with exacerbations of chronic obstructive pulmonary disease.
    Tashiro H; Kurihara Y; Takahashi K; Sadamatsu H; Haraguchi T; Tajiri R; Takamori A; Kimura S; Sueoka-Aragane N
    BMC Pulm Med; 2020 Dec; 20(1):318. PubMed ID: 33287777
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inspiratory capacity and forced expiratory volume in the first second in exacerbation of chronic obstructive pulmonary disease.
    Yetkin O; Gunen H
    Clin Respir J; 2008 Jan; 2(1):36-40. PubMed ID: 20298302
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The PROTECCT-M study: a cohort study investigating associations between novel specific biomarkers, patient-related, healthcare system markers and the trajectory of COPD patients treated in primary care.
    Søndergaard J; Halling A
    BMC Pulm Med; 2014 May; 14():88. PubMed ID: 24886233
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The clinical implication of serum cyclophilin A in patients with chronic obstructive pulmonary disease.
    Zhang M; Tang J; Yin J; Wang X; Feng X; Yang X; Shan H; Zhang Q; Zhang J; Li Y
    Int J Chron Obstruct Pulmon Dis; 2018; 13():357-363. PubMed ID: 29403273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.